Intimation regarding submission of application to BSE for ''In-Principle'' approval of the Scheme of Amalgamation of Emazing Deals Limited into Kaiser Corporation Limited.
M&A
◆ Monitor Closely
MEDIUM RISK
📅 Filed on BSE: 15 Apr 2026, 02:18 PM IST · BSE ID: b5869901-867d-40f7-9dee-bdc7b903866b
View Original BSE Filing (PDF)
💡
In Simple Terms
Kaiser Corporation asked the stock exchange for permission to merge Emazing Deals Limited into itself. The board approved the deal in March; now waiting for shareholder vote and court sign-off.
🤖 AI Summary
- Kaiser Corporation submitted application to BSE April 14, 2026 for merger in-principle approval of Emazing Deals Limited
- Emazing Deals recorded annual turnover of INR 12,227.43 lakhs prior to proposed amalgamation
- Board approval secured March 27, 2026; shareholder and NCLT clearance still required for completion
- Filed under SEBI Regulation 37 and Master Circular on Scheme of Arrangement; Regulation 30 disclosure requirement
- In-principle approval is procedural gateway before shareholder meeting and National Company Law Tribunal court hearing
🔢 Key Numbers — exact figures from BSE filing, not rounded
Emazing Deals Limited annual turnover
INR 12,227.43 lakhs
Application submission date to BSE
April 14, 2026
Board approval date
March 27, 2026
🏢 How This Affects the Company
Amalgamation adds Emazing Deals' operations valued at INR 12,227.43 lakhs turnover to Kaiser's consolidated business. Successful completion consolidates two entities into single operating structure post-NCLT approval.
Merger will combine balance sheets and earnings of both entities. Final financial impact crystallizes only after NCLT approval and scheme effectiveness, bringing Emazing Deals' assets and liabilities into consolidated Kaiser accounts.
Post-completion, combined entity will operate as single legal entity. Current dual-entity structure dissolves into Kaiser Corporation upon NCLT order and scheme effective date, streamlining management and reporting.
Regulatory approval risk remains — shareholder approval and NCLT court clearance required before amalgamation completes. Any shareholder rejection or NCLT denial halts transaction; integration execution risk follows approval.
👥 What This Means For Shareholders
✅
Action Required
Attend shareholder meeting when convened and vote on amalgamation scheme; voting is mandatory step before NCLT petition can be filed.
👤
Who Is Affected
All Kaiser Corporation shareholders will vote on scheme; Emazing Deals shareholders vote separately. Merged entity will list under single Kaiser equity post-NCLT approval; no new shares issued in this filing.
🔍
Management Signal
Board initiated formal regulatory pathway for merger consolidation, signaling strategic intent to integrate Emazing Deals operations and eliminate dual-entity structure.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Shareholder meeting notice and voting outcome — track approval percentage of Kaiser shareholders on amalgamation
NCLT petition filing and court hearing dates — critical regulatory hurdle before scheme becomes effective
NCLT order approval — final legal confirmation triggering scheme implementation and actual business consolidation
MEDIUM RISK
Shareholder and NCLT approvals not yet secured. Court discretion to modify or deny scheme terms. Integration execution risks arise post-approval.
💡 Investor Takeaway
Kaiser Corporation formally initiated merger of Emazing Deals Limited through BSE application April 14, 2026. Emazing Deals turnover stands at INR 12,227.43 lakhs. In-principle approval is procedural; completion requires shareholder vote and NCLT court order — expected within 4–6 months.
⚖️ Strengths & Concerns
✅ Positives
- Board approval already secured March 27, 2026, confirming internal governance completion and director confidence in deal
- Target company turnover at INR 12,227.43 lakhs establishes material scale and consolidates established revenue base post-merger
⚠️ Concerns
- Shareholder approval not yet obtained; dissenting shareholders can block amalgamation in upcoming shareholder meeting vote
- NCLT court approval mandatory but not assured; court retains absolute discretion to approve, reject, or modify scheme terms
📅 Company Track Record
Kaiser board approved Emazing Deals merger March 31, 2026. Emazing Deals annual turnover disclosed at INR 12,227.43 lakhs. Board meeting scheduled March 27, 2026 confirmed merger voting. No prior dividend, acquisition, or stock split history provided in available filings.
Based on publicly available historical data. For context only.